Objective. The purpose of this study was to assess the value of reattempting the nuchal translucency (NT) measurement after an initial failure. Methods. Women undergoing NT measurements by NT-certified sonographers within a combined screening program over an 18-month period were categorized as "desiring" screening (all women), "eligible" (live fetus with crown-rump length of 45-84 mm), and "defaulters" (failed to keep a visit after a failed NT measurement attempt). If the NT measurement was unobtainable, patients with live fetuses and a crown-rump length of less than 84 mm were offered reexamination. Results. Nuchal translucency measurement success rates at the initial visit for those desiring (n = 837) and eligible (n = 767) were 73.3% and 80.0%, respectively. Composite NT measurement success rates for up to 3 visits were significantly greater than for only 1 visit for those desiring screening (84.8%; P < .0001), eligible for screening (86.6%; P = .0004), and not defaulting on follow-up (97.0%; P < .0001). The screen-positive rates were similar for 1 and up to 3 visits (10.4% and 11.0%). One additional (16.6%) aneuploidy was detected through a second visit. Conclusions. Reattempting NT measurements significantly increases the overall NT measurement success rate and detects additional aneuploidies at constant screen-positive and invasive prenatal diagnosis rates. Key words: Down syndrome; nuchal translucency; prenatal diagnosis. ombined screening, using fetal nuchal translucency (NT) measurement with maternal serum β-human chorionic gonadotropin and pregnancy-associated plasma protein A levels, is a widely accepted means of assessing risk for trisomies 18 and 21.1,2 Accurate screening requires strict adherence to stringent NT imaging criteria.2,3 Not surprisingly, some series report NT measurement failure rates of up to 25%. Therefore, we performed a retrospective cohort study to assess the value of reattempting NT measurements after the initial attempt failed.